Effects of Public Health Insurance Expansions on the Non-Healthcare Consumption Expenditures of Low-Income Households

2020 ◽  
Author(s):  
Thadchaigeni Panchalingam
1995 ◽  
Vol 20 (4) ◽  
pp. 955-972 ◽  
Author(s):  
Carolyn W. Madden ◽  
Allen Cheadle ◽  
Paula Diehr ◽  
Diane P. Martin ◽  
Donald L. Patrick ◽  
...  

Author(s):  
Najam uz Zehra Gardezi

Abstract Public health insurance targeted towards low-income households has gained traction in many developing countries. However, there is limited evidence as to the effectiveness of these programs in countries where institutional constraints may limit participation by the eligible population. This paper evaluates a recent health insurance initiative introduced in Pakistan and discusses whether eligibility for the programme improves maternal health seeking behaviour. The Prime Minister National Health Program provides free insurance coverage to low-income families. The programme is in the early phases of implementation and has, since 2016, only been rolled out in a few eligible districts within the country. This allows for a comparison of eligible households in districts where the programme has been introduced to those that are eligible to receive insurance at a future date. Using repeated cross-sectional data from multiple rounds of representative household survey, a difference-in-difference model has been estimated. Results show that at least for a specific beneficiary group (i.e. pregnant women), there has been a positive increase in utilization of hospital services. Furthermore, we provide evidence using mother fixed effects that the programme increased the likelihood of a child’s birth being documented. Since possession of a birth certificate can secure civic rights for a child, this is an unintended but positive outcome of the programme.


2020 ◽  
Vol 174 (1) ◽  
pp. 22 ◽  
Author(s):  
Vasil I. Yasenov ◽  
Duncan Lawrence ◽  
Fernando S. Mendoza ◽  
Jens Hainmueller

2017 ◽  
Vol 4 (3) ◽  
pp. 61-69 ◽  
Author(s):  
Rose L Harding ◽  
Jennifer D Hall ◽  
Jennifer DeVoe ◽  
Heather Angier ◽  
Rachel Gold ◽  
...  

2019 ◽  
Vol 37 (15_suppl) ◽  
pp. 10037-10037
Author(s):  
Neela Lakshmi Penumarthy ◽  
Robert Goldsby ◽  
Lena Penumarthy

10037 Background: Racial and ethnic survival disparities have been described for many pediatric malignancies, but the impact of income has not been extensively explored. To assess whether socioeconomic status affects outcomes, we evaluated low-income public health insurance as a proxy. We analyzed how low-income public health insurance influences overall survival in children, adolescents, and young adults diagnosed with bone and soft tissue sarcomas. Methods: The University of California San Francisco Cancer Registry was used to identify patients age 0-39 diagnosed with bone or soft tissue sarcomas between 2000-2015. Low-income patients were defined as those with Medicaid, which is only available under state law to eligible low-income individuals or families, or those with no insurance. The comparison group included all other patients with private insurance, Medicare, or Tricare. Survival curves were computed using the Kaplan-Meier method and compared using log-rank tests and Cox models. Logistic regression was used to investigate the association of low-income public insurance and presence of metastatic disease at diagnosis. Results: A total of 1,106 patients were included in the analysis. 444 (40%) were considered low-income; of these, 428 (39%) had public insurance and 16 (1%) had no insurance. Low-income patients were more likely to both be racial/ethnic minorities and present with metastatic disease on multivariable analysis. Low-income patients had significantly worse 5-year OS (61% vs 71%, p = 0.0003). When stratified by localized, regional, or metastatic disease, low-income patients consistently had significantly worse 5-year OS (localized: 78% vs 84%, regional: 64% vs 73%, metastatic: 23% vs 30% respectively, p < 0.0001). Age and race/ethnicity did not significantly impact OS in this study population. Conclusions: Low-income patients with bone and soft tissue sarcomas had decreased overall survival. While these patients were more likely to have metastatic disease, disparities in survival were noted even within the localized and regional disease groups. The means by which insurance status impacts survival requires additional investigation, but may be through reduced access to care.


Author(s):  
Qing Yang ◽  
Qing Xu ◽  
Yufeng Lu ◽  
Jin Liu

A large body of literature has shown that the burden of healthcare can push individuals and households into the burden of medical care and income loss. This makes it difficult for rural or low-income households to obtain and use safe and affordable formal credit services. In 2003, China’s government implemented a new rural public health insurance, which was called the New Rural Cooperative Medical Scheme (NRCMS). This study provides evidence of the impact of NRCMS on household credit availability using the China Family Panel Studies (CFPS) for 2010. The tobit regression approach and mediator model are used. The results show that, as a public health insurance system sustained by the participation of government investment, the NRCMS provides good “collateral” and significantly enhances rural households’ formal credit availability level. Furthermore, this positive effect is mainly reflected in the economic effect of NRCMS. Our results are robust to alternative statistical methods. Our findings suggest that expanding access, fulfilling the NRCMS mortgage function, and providing more financial services for rural households would have big benefits with regard to easing credit constraints for rural residents.


Significance High and rising case numbers have strained public and private health systems. Medicaid, which caters to low-income families and will experience surging demand as job losses rise, is in particular distress, mainly because states co-fund and administer it. The strains are propelling healthcare reform as an electoral issue. Impacts Biden is unlikely to endorse ‘Medicare for all’ but will push his public health insurance option. The Republicans will struggle to elucidate a clear alternative to the Affordable Care Act before November. COVID-19 will fuel calls for Medicaid expansion, including in smaller conservative states.


2017 ◽  
Vol 31 (4) ◽  
pp. 3-22 ◽  
Author(s):  
Jonathan Gruber

The United States has seen a sea change in the way that publicly financed health insurance coverage is provided to low-income, elderly, and disabled enrollees. When programs such as Medicare and Medicaid were introduced in the 1960s, the government directly reimbursed medical providers for the care that they provided, through a classic “single payer system.” Since the mid-1980s, however, there has been an evolution towards a model where the government subsidizes enrollees who choose among privately provided insurance options. In the United States, privatized delivery of public health insurance appears to be here to stay, with debates now focused on how much to expand its reach. Yet such privatized delivery raises a variety of thorny issues. Will choice among private insurance options lead to adverse selection and market failures in privatized insurance markets? Can individuals choose appropriately over a wide range of expensive and confusing plan options? Will a privatized approach deliver the promised increases in delivery efficiency claimed by advocates? What policy mechanisms have been used, or might be used, to address these issues? A growing literature in health economics has begun to make headway on these questions. In this essay, I discuss that literature and the lessons for both economics more generally and health care policymakers more specifically.


Sign in / Sign up

Export Citation Format

Share Document